pilocarpine has been researched along with 1-(3-trifluoromethylphenyl)piperazine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, DF; Wirtshafter, D | 1 |
| Dudek, FE; Hernandez, EJ; Williams, PA | 1 |
2 other study(ies) available for pilocarpine and 1-(3-trifluoromethylphenyl)piperazine
| Article | Year |
|---|---|
Quinpirole attenuates striatal c-fos induction by 5-HT, opioid and muscarinic receptor agonists.
Topics: Amphetamines; Animals; Corpus Striatum; Dopamine Agonists; Fenfluramine; Immunohistochemistry; Indoles; Male; Morphine; Muscarinic Antagonists; Pilocarpine; Piperazines; Proto-Oncogene Proteins c-fos; Quinpirole; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Opioid, mu; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists | 1998 |
Effects of fluoxetine and TFMPP on spontaneous seizures in rats with pilocarpine-induced epilepsy.
Topics: Animals; Convulsants; Epilepsy; Fluoxetine; Male; Pilocarpine; Piperazines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sodium Chloride; Time Factors | 2002 |